TWILIGHT LITAKA PHARMA LTD.

NSE : NABSE : 506985ISIN CODE : INE783B01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE2.880 (0 %)
PREV CLOSE ( ) 2.88
OPEN PRICE ( ) 2.88
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2.88 (112420)
VOLUME 2574
TODAY'S LOW / HIGH ( )2.88 2.88
52 WK LOW / HIGH ( ) 2.882.88
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsJun2014Jun2013Mar2012Mar2011Mar2010
Profit Before Tax-1402.00-1710.092.20656.29405.52
Adjustment1427.511853.23523.46351.81237.42
Changes In working Capital-8.44-188.65-481.83-1013.59-431.38
Cash Flow after changes in Working Capital17.07-45.5143.82-5.50211.55
Cash Flow from Operating Activities15.20-54.6138.62-77.21141.73
Cash Flow from Investing Activities-3.580.75-188.85-256.13-295.69
Cash Flow from Financing Activities-6.5939.86139.20302.69170.58
Net Cash Inflow / Outflow5.03-14.00-11.03-30.6416.61
Opening Cash & Cash Equivalents4.2318.2329.2659.9142.99
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent9.264.2318.2329.2659.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.